Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP1001651.RALTY2QS_5meDAZPZPaMTDQ0S09K3E68B2CGWAmHN8Wrg130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP1001651.RALTY2QS_5meDAZPZPaMTDQ0S09K3E68B2CGWAmHN8Wrg130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP1001651.RALTY2QS_5meDAZPZPaMTDQ0S09K3E68B2CGWAmHN8Wrg130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP1001651.RALTY2QS_5meDAZPZPaMTDQ0S09K3E68B2CGWAmHN8Wrg130_provenance.
- NP1001651.RALTY2QS_5meDAZPZPaMTDQ0S09K3E68B2CGWAmHN8Wrg130_assertion description "[No allelic variant was detected for hsa-mir-17 and hsa-mir-369, and allelic and genotype frequencies for miR-146a rs2910164 single-nucleotide polymorphism (SNP) were comparable with that of 155 controls from the same population, ruling out a role for genetic variations in these three miRNAs as major determinants in cancer predisposition of BRCA1/BRCA2-negative patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1001651.RALTY2QS_5meDAZPZPaMTDQ0S09K3E68B2CGWAmHN8Wrg130_provenance.
- NP1001651.RALTY2QS_5meDAZPZPaMTDQ0S09K3E68B2CGWAmHN8Wrg130_assertion evidence source_evidence_literature NP1001651.RALTY2QS_5meDAZPZPaMTDQ0S09K3E68B2CGWAmHN8Wrg130_provenance.
- NP1001651.RALTY2QS_5meDAZPZPaMTDQ0S09K3E68B2CGWAmHN8Wrg130_assertion SIO_000772 20810544 NP1001651.RALTY2QS_5meDAZPZPaMTDQ0S09K3E68B2CGWAmHN8Wrg130_provenance.
- NP1001651.RALTY2QS_5meDAZPZPaMTDQ0S09K3E68B2CGWAmHN8Wrg130_assertion wasDerivedFrom befree-20150227 NP1001651.RALTY2QS_5meDAZPZPaMTDQ0S09K3E68B2CGWAmHN8Wrg130_provenance.
- NP1001651.RALTY2QS_5meDAZPZPaMTDQ0S09K3E68B2CGWAmHN8Wrg130_assertion wasGeneratedBy ECO_0000203 NP1001651.RALTY2QS_5meDAZPZPaMTDQ0S09K3E68B2CGWAmHN8Wrg130_provenance.
- befree-20150227 importedOn "2015-02-27" NP1001651.RALTY2QS_5meDAZPZPaMTDQ0S09K3E68B2CGWAmHN8Wrg130_provenance.